Patent assignee · US · COMPANY

Synergen, Inc

14Patents
1Active
14Granted
30Portfolio score

Filing activity: Sep 26, 1983 → Oct 8, 2008 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US5075222A Interleukin-1 inhibitors Human Necessities 138 Expired
US4994559A Human basic fibroblast growth factor Emerging Cross-Sectional Technologies 52 Expired
US5235043A Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins Emerging Cross-Sectional Technologies 50 Expired
US4997929A Purified ciliary neurotrophic factor Human Necessities 48 Expired
US5141856A Expression of purified ciliary neurotrophic factor Human Necessities 45 Expired
US5332804A High molecular weight human angiogenic basic fibroblast growth factors Human Necessities 35 Expired
US5026839A DNA encoding a basic fibroblast growth factor Chemistry; Metallurgy 26 Expired
US5453490A Production of recombinant human interleukin-1 inhibitor Chemistry; Metallurgy 12 Expired
US5459048A DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals Human Necessities 8 Expired
US5188943A Method of producing high molecular weight human fibroblast growth factors Human Necessities 5 Expired
US8006740B2 High performance brake rotor Performing Operations; Transporting 5 Active
US5079145A Process for preparing microorganisms used for making phenyl acetyl carlinol (PAC) Emerging Cross-Sectional Technologies 4 Expired
US4690897A Method for transformation of anaerobic microorganisms Emerging Cross-Sectional Technologies 2 Expired
US5312742A Process for making L-phenyl acetyl carbinol (PAC), microorganisms for use in the process, and a method of preparing the microorganisms Emerging Cross-Sectional Technologies 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.